(Q41786017)

9 October 2017

D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). (English)

1 reference

9 October 2017

0 references

0 references

Madras BK

1

1 reference

9 October 2017

Fahey MA

series ordinal

2

1 reference

9 October 2017

Canfield DR

series ordinal

3

1 reference

9 October 2017

Spealman RD

series ordinal

4

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

Journal of Neurochemistry

9 October 2017

1 reference

9 October 2017

51

1 reference

9 October 2017

3

1 reference

9 October 2017

934-943

1 reference

N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists

9 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Species variations in dopamine receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Dopamine receptor subtype imbalance in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Human brain dopamine receptors in children and aging adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1988.TB01830.X

10.1111/J.1471-4159.1988.TB01830.X

21 January 2018

Identifiers

DOI

1 reference

9 October 2017

1 reference